T hough it's a very simple statement, it's not as easy as it seems to ''do no harm.'' A discussion I had with an anesthesiologist revealed his concerns that the emphasis on pain scores may be associated with unanticipated negative events. He may be right. According to a study published in 2005, researchers evaluated patient satisfaction data and adverse drug reaction (ADR) data before and after updated pain management standards incorporated ''pain as the fifth vital sign'' at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. Although patient satisfaction data improved, they reported that opioid ADRs and opioid oversedation or respiratory depression increased after implementation. As a result, the researchers reported that the institution implemented an updated pain/consciousness rating scale that incorporated clinical assessment of patient consciousness in addition to a numeric pain scale. 1 Risk Evaluation and Mitigation Strategies (REMS) programs were developed with the objective of ensuring that the benefits of a drug or biological product outweigh its risks. 2 I had been frustrated with the variation in processes outlined by various REMS programs and attended a session at the 2010 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting that focused on these programs. One presenter shared a review of the iPledge program for isotretinoin distribution at Kaiser Permanente. Although the program is intended to prevent pregnancies in females taking the drug and prevent drug administration to pregnant patients, one study revealed that an unintended consequence of the program has been reduced prescribing for the drug overall, including male patients. [3] [4] [5] I walked out of the session more frustrated than before. Not only has it been challenging to implement REMS programs in the inpatient setting, but these programs may have unknown negative effects.
Recently approved meaningful use regulations have incorporated computerized prescriber order en-try (CPOE), which will promote its adoption nationally. The Leapfrog Group has praised the move, but cautioned that health systems are not required to demonstrate that their CPOE systems work as intended before federal funds are awarded. Although CPOE systems reduce the occurrence of some error types, studies have documented error types that are undetected, or are even introduced, by these technologies.
In their statement, The Leapfrog Group cited one of their recent reports that revealed that half of the errors evaluated in a simulation study among 214 hospitals were undetected by the CPOE systems. 6 In another study, researchers categorized unintended adverse consequences observed at 5 hospitals with CPOE. The authors defined these categories as more/new work for clinicians, unfavorable workflow issues, neverending system demands, problems related to paper persistence, untoward changes in communication patterns and practices, negative emotions, generation of new kinds of errors, unexpected changes in the power structure, and overdependence on the technology. 7 In a separate study, the same researchers further evaluated the effects of overdependence on CPOE technology. Three prominent problems included patient safety compromise and practice disruption during system downtime, false expectations for accuracy and processing, and a perception that clinicians cannot work efficiently in the absence of CPOE. 8 A trial conducted at 2 academic medical centers in Philadelphia evaluated the impact of a nearly hard-stop intervention to reduce the concomitant use of warfarin and sulfamethoxazole/ trimethoprim. The trial was halted early because 4 patients experienced clinically significant delays due to the intervention when immediate therapy was indicated. 9 In the New England Journal of Medicine last fall, The Joint Commission addressed ORYX core quality measures that have been designated as accountability *Saint Francis Hospital, Tulsa Oklahoma. measures effective January 1, 2012. 10 Hospitals will be required to demonstrate an 85% composite compliance target rate on designated measures in order to avoid a Requirement for Improvement (RFI). 11 The author addressed the importance of developing measures with minimal or no unintended adverse consequences. One example is the goal of timely antibiotic administration in patients presenting with community acquired pneumonia; studies have demonstrated that attempts to adhere to this goal also lead to inappropriate administration of antibiotics in patients without pneumonia. 10, 12, 13 The complexity of medication use systems and a growing number of resource-intensive national initiatives introduce risk for unintended negative consequences. In addition to these national initiatives, hospital pharmacies must continue to implement programs and process improvements designed for their own distinct needs that require monitoring for unintended negative effects.
As growing medication use system needs intersect with finite professional resources, it becomes increasingly difficult to develop sound programs with adequate monitoring systems. Attention is fragmented between national pressures and local needs. The underlying challenge is to avoid preventable errors that occur because pharmacy resources are spread too thin to develop robust monitoring systems without fail.
The development of proactive monitoring plans should help mitigate the sense that we're all playing a game of Whac-A-Mole when problems emerge. As hospital pharmacists, we must seize these opportunities to continue to demonstrate value as medication use process experts in an evolving professional environment.
